Abstract 3511: A T cell engager (TCE), HB134, targeting LILRB4 and CD3, exhibits potent anti-tumor activity with a favorable safety profile for monocytic AML
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Juan Liu, Fangfang Ren, Chunmei Liu, Jing Shao, Fang Yang, Jianhe Chen, Bin Ye, Jianhua Sui
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409624587
